小MAF转录因子MAFG与MITF合作,促进黑色素瘤的进展
Olga Vera1,2,3, Michael Martinez1, Zulaida Soto-Vargas1
1Department of Molecular Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612, USA.
bioRxiv : the preprint server for biology
|September 16, 2024
概括
一种转录因子MAFG通过改变基因表达来驱动黑色素瘤的进展. 它与MITF合作,促进瘤生长和脱差,提供新的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 转录因子放松调控是黑色素瘤进展的关键驱动因素.
- 此前,MAFG (小MAF家族转录因子) 被确定为潜在的黑色素瘤驱动因素.
研究的目的:
- 研究MAFG在黑色素瘤进展中的作用.
- 为了阐明MAFG驱动黑色素瘤的机制.
主要方法:
- 在人类黑色素瘤阶段评估MAFG表达.
- 试管室外MAFG表达的评估效应,异种移植和小鼠模型.
- 研究了MAFG-MITF相互作用和基因组遗址的共同占用.
- 分析了MAFG过度表达细胞中的基因表达变化.
主要成果:
- 随着黑色素瘤的发展阶段,MAFG的表达增加.
- 宫外MAFG增强了黑色素瘤细胞恶性病变,并诱导了脱差.
- MAFG与MITF进行物理相互作用,这对其抗瘤作用至关重要.
- MAFG-MITF复合体共同占据基因组位点并调节基因表达.
结论:
- MAFG 是黑色素瘤进展的强有力的驱动因素.
- MAFG通过与MITF形成复合物来促进黑色素的产生.
- 这项研究揭示了黑色素瘤中MITF调节的新机制.
相关概念视频
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
MAPK Signaling Cascades
5.3K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.3K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
TGF - β Signaling Pathway
7.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K


